6226 - 6250 of 9145 Results
Title
Year
-
OPENTitle: Metadata Concepts for Advancing the Use of Digital Health Technologies in Clinical ResearchJournal Name: Digital BiomarkersPublisher: S. Karger AGVol: 3Issue #: 3Start Page: 116End Page: 132Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1159/000502951Best OA location URL: https://www.karger.com/Article/Pdf/502951Citation Count: 46
- Media hype: Patient and scientific perspectives on misleading medical news2017RESTRICTEDTitle: Media hype: Patient and scientific perspectives on misleading medical newsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 9Start Page: 1319End Page: 1323Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26993Citation Count: 44
- Biomarkers for Parkinson’s Disease2011RESTRICTEDTitle: Biomarkers for Parkinson’s DiseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 3Issue #: 79Start Page: 79ps14End Page: 79ps14Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.3002488Citation Count: 42
-
OPENTitle: Population‐specific frequencies for LRRK2 susceptibility variants in the genetic epidemiology of Parkinson's disease (GEO‐PD) consortiumJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 12Start Page: 1740End Page: 1744Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25600Best OA location URL: http://hdl.handle.net/11573/1383084Citation Count: 41
- Enabling breakthroughs in Parkinson’s disease with wearable technologies and big data analytics2016OPENTitle: Enabling breakthroughs in Parkinson’s disease with wearable technologies and big data analyticsJournal Name: mHealthPublisher: AME Publishing CompanyVol: 2Issue #:Start Page: 20End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.21037/mhealth.2016.04.02Best OA location URL: https://mhealth.amegroups.com/article/viewFile/10369/pdfCitation Count: 35
- Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐lesioned primate model of Parkinson's disease2014RESTRICTEDTitle: Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐lesioned primate model of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 6Start Page: 772End Page: 779Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25859Citation Count: 40
-
OPENTitle: Impact of motor fluctuations on real-life gait in Parkinson’s patientsJournal Name: Gait & PosturePublisher: Elsevier BVVol: 62Issue #:Start Page: 388End Page: 394Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.gaitpost.2018.03.045Best OA location URL: https://publications.aston.ac.uk/id/eprint/33121/1/1_s2.0_S0966636218302832_main.pdfCitation Count: 34
-
OPENTitle: Design of a virtual longitudinal observational study in Parkinson’s disease (AT‐HOME PD)Journal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 8Issue #: 2Start Page: 308End Page: 320Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51236Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51236Citation Count: 33
-
OPENTitle: Nilotinib – Differentiating the Hope from the HypeJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 6Issue #: 3Start Page: 519End Page: 522Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-160904Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd160904?id=journal-of-parkinsons-disease%2Fjpd160904Citation Count: 32
-
OPENTitle: Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson’s Disease 1Journal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 5Issue #: 3Start Page: 581End Page: 594Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-150570Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd150570?id=journal-of-parkinsons-disease%2Fjpd150570Citation Count: 30
-
OPENTitle: Comparison of an Online-Only Parkinson’s Disease Research Cohort to Cohorts Assessed In PersonJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 677End Page: 691Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191808Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191808?id=journal-of-parkinsons-disease%2Fjpd191808Citation Count: 28
-
OPENTitle: The commercial genetic testing landscape for Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 107End Page: 111Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.001Best OA location URL: http://www.prd-journal.com/article/S1353802021003564/pdfCitation Count: 29
-
OPENTitle: The Michael J. Fox Foundation for Parkinson’s Research Strategy to Advance Therapeutic Development of PINK1 and ParkinJournal Name: BiomoleculesPublisher: MDPI AGVol: 9Issue #: 8Start Page: 296End Page: 296Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom9080296Best OA location URL: https://www.mdpi.com/2218-273X/9/8/296/pdfCitation Count: 26
-
OPENTitle: Palliative Care and Parkinson's Disease: Time to Move Beyond CancerJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1325End Page: 1329Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28556Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8217287Citation Count: 24
-
OPENTitle: A Call to Action: Promoting Diversity, Equity, and Inclusion in Parkinson’s Research and CareJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 3Start Page: 905End Page: 908Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212593Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212593?id=journal-of-parkinsons-disease%2Fjpd212593Citation Count: 26
-
OPENTitle: Parkinson’s Patients’ Tolerance for Risk and Willingness to Wait for Potential Benefits of Novel Neurostimulation Devices: A Patient-Centered Threshold Technique StudyJournal Name: MDM Policy & PracticePublisher: SAGE PublicationsVol: 6Issue #: 1Start Page: 2381468320978407End Page: 2381468320978407Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/2381468320978407Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/2381468320978407Citation Count: 23
-
OPENTitle: Recruitment for Remote Decentralized Studies in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 1Start Page: 371End Page: 380Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212935Best OA location URL: https://escholarship.org/uc/item/0k98f47rCitation Count: 22
-
OPENTitle: Using Qualitative Methods to Understand Physical Activity and Weight Management Among Bangladeshis in New York City, 2013Journal Name: Preventing Chronic DiseasePublisher: Centers for Disease Control and Prevention - Preventing Chronic DiseaseVol: 13Issue #:Start Page: E87End Page: E87Publication Date:Open Access(OA) Status: OPENLicense: public-domainDOI - Digital Object Identifier: 10.5888/pcd13.160077Best OA location URL: https://www.cdc.gov/pcd/issues/2016/pdf/16_0077.pdfCitation Count: 23
-
OPENTitle: The Experience of OFF Periods in Parkinson’s Disease: Descriptions, Triggers, and Alleviating FactorsJournal Name: Journal of Patient-Centered Research and ReviewsPublisher: Aurora Health Care, Inc.Vol: 8Issue #: 3Start Page: 232End Page: 238Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.17294/2330-0698.1836Best OA location URL: https://institutionalrepository.aah.org/cgi/viewcontent.cgi?article=1836&context=jpcrrCitation Count: 18
- Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trial2023RESTRICTEDTitle: Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 114Issue #:Start Page: 105511End Page: 105511Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105511Citation Count: 13
-
OPENTitle: Understanding the Lexicon of Fatigue in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 3Start Page: 1185End Page: 1193Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-202029Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202029?id=journal-of-parkinsons-disease%2Fjpd202029Citation Count: 15
-
OPENTitle: The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variantsJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 1Start Page: 266.e5End Page: 266.e14Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2013.07.013Best OA location URL: https://www.sciencedirect.com/science/article/pii/S0197458013003187Citation Count: 41
- DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.2017RESTRICTEDTitle: DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.Journal Name: NeuropharmacologyPublisher: Elsevier BVVol: 131Issue #:Start Page: 116End Page: 127Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2017.11.046Citation Count: 20
-
OPENTitle: Isogenic human SNCA gene dosage induced pluripotent stem cells to model Parkinson’s diseaseJournal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 60Issue #:Start Page: 102733End Page: 102733Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2022.102733Best OA location URL: https://doi.org/10.1016/j.scr.2022.102733Citation Count: 8
-
OPENTitle: Lack of association between G6PD variants and Parkinson diseaseJournal Name: Human Genetics and Genomics AdvancesPublisher: Elsevier BVVol: 7Issue #: 1Start Page: 100555End Page: 100555Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.xhgg.2025.100555Best OA location URL: https://doi.org/10.1016/j.xhgg.2025.100555Citation Count: 0